Supplementary Table 2 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates

Supplementary Table 2. Antibodies and dilutions used in Cyclic Immunofluorescence (CyCIF) with vendor, catalogue number, and dilution used for each marker.

补充表 2. 在循环免疫荧光（CyCIF）中使用的抗体及其稀释比例，包含供应商、目录编号以及每个标记物的使用稀释度。